INTRODUCTION
The USA is currently witnessing a vaping epidemic. Despite the rising popularity of electronic nicotine delivery systems (ENDS) or e-cigarette use (vaping), there is a limited understanding of public perceptions about the health effects of these products. While scientific evidence about the long-term health effects is inconclusive, emerging findings suggest that vaping is linked to cancer, cardiovascular, respiratory, and other health issues.1 An understanding of public perceptions about the health effects of vaping can help identify priority areas for patient education in clinician settings. Social media surveillance of public perceptions of the health effects of vaping may inform patient-provider interactions, and complement findings from traditional survey research at a low cost.2 This study characterizes public conversations about the health effects of vaping on Twitter during 2018 and 2019.
METHODS
Vaping-related posts (n = 2,516,664 posts in 2018, n = 2,731,399 posts in 2019, total n = 5,248,063) were obtained from January 1, 2018, to December 31, 2019, using Twitter’s Streaming Application Program Interface (API). Data cleaning procedures included removal of retweets so that each observation could be treated as an independent unit of observation, and removal of posts from bot accounts.3 Posts containing health-related references to e-cigarettes were identified using two dictionaries: (a) the Unified Medical Language System® (UMLS) Consumer Health Vocabulary (CHV), 4 comprising n=13,479 informal, common medical terms used by consumers and health care professionals; and (b) a list of n=177 additional informal terms corresponding to the CHV terms, wherever relevant (e.g., informal term of “inebriation” is “drunk”). Keywords from the two dictionaries encompassed health diseases and symptoms (referred to as “health effects” in this study). A total sample of n = 667,140 (n = 257,620 posts in 2018; n = 409,520 posts in 2019) e-cigarette-related posts with mentions of health effects were identified. Each post in the analytic sample was then classified to one or more of the 14 categories of health effects (see Table 1).
RESULTS
Percentage distribution of categories of health effects by 2018 and 2019 is reported in Figure 1. In 2018, Neurological effects (n = 44,345; 17.2%) were the most common, followed by Mental Health (n = 31,227; 12.1%) and Death (n = 27,040; 10.5%). In 2019, Death was most commonly referenced (n = 77,719; 19.0%), followed by references to Neurological (n = 67,504; 16.5%) and Respiratory (n = 48,875; 11.9%) health effects in 2019. Compared to 2018, Death, Mental health, and Respiratory health effects were more prevalent in 2019. Respiratory health effects emerged as part of the top five categories in 2019.
DISCUSSION
Neurological, Death, Mental Health, and Respiratory were all predominant categories of vaping-related health effects during 2018 and 2019 on Twitter. These findings may be relevant to primary healthcare providers as they counsel patients on the health risks associated with e-cigarette use.5 Armed with the insights from this study, clinicians can help patients better understand ways in which vaping may contribute to the abovementioned health effects. Chronic health conditions such as Cancer, cardiovascular diseases may also warrant consideration while discussing the potential long-term health risks of vaping since they may be less salient among patients. Respiratory health effects, a predominant category in 2019, may be potentially attributable to the outbreak of lung injuries associated with the use of vape products during that year.6 Findings will also inform future survey-based public health surveillance efforts and toxicology research examining long-term and short-term health effects of vaping.
This study drew data from public Twitter posts. Findings may not generalize to other social media platforms and may not represent data from individuals with private Twitter accounts. Specific references to the biological basis of the health effects (e.g., mentions of blocked arteries in the context of heart dysfunction) may not be captured in this study. While this study collected data from two different years, findings may not extend to other time periods.
Despite these limitations, findings may serve as a useful baseline to identify emerging categories and monitor predominant categories of perceived health effects of vaping in general and by source (e.g., news organizations, public health agencies) in the future. Unexpected peaks in reported categories of health effects may also help inform the surveillance of potential vaping-related outbreaks. Taken altogether, characterizing the public’s expressions of the health effects of vaping through Twitter data can offer insights to medical providers and inform survey-based research in the future.
References
Glantz SA, Bareham DW. E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications. Annu Rev Public Health. 2018;39(1):215-235.
Allem J-P, Ferrara E, Uppu SP, Cruz TB, Unger JB. E-cigarette surveillance with social media data: Social bots, emerging topics, and trends. JMIR Public Health Surveillance. 2017;3(4):e98.
Allem J-P, Dharmapuri L, Unger JB, Cruz TB. Characterizing JUUL-related posts on Twitter. Drug Alcohol Depend. 2018;190:1-5.
Zeng QT, Tse T. Exploring and developing consumer health vocabularies. Journal of American Medical Informatics Association. 2006;13(1):24-29.
Peterson EB, Fisher CL, Zhao X. Pediatric primary healthcare providers’ preferences, experiences and perceived barriers to discussing electronic cigarettes with adolescent patients. Journal of Communication in Healthcare. 2018;11(4):245-251.
CDC. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Published 2020. Accessed 29 Jan 2020
Acknowledgements
The authors would like to thank Dr. Pablo Barberá, Associate Professor, Department of Political Science and International Relations at the University of Southern California, for his valuable inputs.
Funding
Research reported in this publication was supported by Grant # U54CA180905 from the National Cancer Institute and the FDA Center for Tobacco Products (CTP).
Author information
Authors and Affiliations
Contributions
Conceptualization: AM
Data collection: AM
Data analysis: AM
First draft of the manuscript: AM
Critical review of the manuscript: AM, JPA, TBC, JBU, MAP
Corresponding author
Ethics declarations
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or FDA. The first author was affiliated with the University of Southern California, Department of Preventive Medicine during data colelction, analysis and manuscript preparation.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Majmundar, A., Allem, JP., Cruz, T.B. et al. Monitoring Health Effects of Vaping Discussed on Twitter in 2018 and 2019. J GEN INTERN MED 37, 673–675 (2022). https://doi.org/10.1007/s11606-021-06705-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-021-06705-9